Press releases
- Trinity Capital Inc. Expands Life Sciences Operations with Appointment of Joshua Ruben as Managing Director
- Trinity Capital Inc. Provides Details for Second Quarter 2024 Financial Results and Conference Call
- Trinity Capital Inc. Funds Record $474 Million in the First Half of 2024
- Trinity Capital Inc. Prices Offering of $100.0 Million of 7.875% Notes due 2029
- Trinity Capital Inc. Provides $15 Million in Growth Capital to Velentium
- Trinity Capital Inc. Announces Adjustment to Conversion Rate of its 6.00% Convertible Notes due 2025
- Trinity Capital Inc. Provides $40 Million in Growth Capital to Gravie
- Trinity Capital Inc. Declares Cash Dividend of $0.51 per Share for the Second Quarter of 2024
- Trinity Capital Inc. Exits Its Equity Position in Core Scientific
- Trinity Capital Inc. Provides $15 Million in Growth Capital to restor3d
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 24.80 |
---|---|
High | 24.98 |
Low | 24.80 |
Bid | 24.91 |
Offer | 24.97 |
Previous close | 24.97 |
Average volume | -- |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Jul 22 2024 21:00 BST.
More ▼